after treatment with a melanoma cell vaccine preceded by cyclophosphamide. 
r^rpr Res. 46: 2572-2577, 1986. 
59. Hearing, V.J., Gersten, D.M., Montague, P.M. et al. Murine 
melanoma-specific tumor rejection activity elicited by a purified 
melanoma associated antigen. J, Immunol . 17: 79-85, 1986. 
60. 3rystrn, J-C. Antibody response and tumor growth in syngeneic mice 
immunized to partially purified B16 melanoma associated antigens. J. Immunol . 
120: 96-101, 1978. 
61. Van den Eynde, B., Hainaut, P., Herin, M., Knuth, A., Lemoine, C., 
Weynants, P. van der Bruagen, P. Fauchet, R. and Boon, T. Presence on a human 
melanoma of multiple antigens recognized by autologous CTL. Int. J. Cancer 44: 
634-640, 1989. 
62. Hein, M., Lemoine, C., Weynants, P., Vessiere, F., Van Pel, A., Knuth, A. 
Devos, R. and Boon, T. Production of stable cytolytic T-cell clones directed 
against autologous human melanoma. Int. J. Cancer 39: 390-396, 1987. 
63. Restivo, N.P., Esquivel, F., Asher, A.L., Stottre, H., Barth, J.R., 
Bennink, J.R., Mule, J.J., Yewdell, J.W. and Rosenberg, S.A. Defective 
presentation of endogenous antigens by a murine sarcoma: Implications for the 
failure of an anti tumor immune response. J. Immunol. 147: 1453-1' J , 1991. 
64. Ohlen, C., Bastin, J., Ljunggren, H.G., Foster, L., Wolpert, E., Klein, 
G. , Townsend, A.R.M. and Karre, K. Resistance to H-2-restricted but not to allo- 
H-2-specific graft and cytotoxic T lymphocyte responses in lymphoma mutant. J . 
Immunol . 145: 52, 1990. 
65. Hewitt, H.B., Blake, E.R. and Walder, E.S. A critique of the evidence for 
active host defense against cancer based on personal studies of 27 murine 
tumors of spontaneous origin. Br. J. Cancer . 33: 241,1976. 
66. Madden, D.R., Gorge, J.C., Strominger, J.L. and Wiley, D.C. The structure 
of HLA B27 reveals nonamer self-peptides bound in an extended conformation. 
Nature (Lond. ) 353: 321, 1991; 
67. Falk, K., Rotzschke, 0., Deres, K., Metzger, J., Jung, G. and Rammensee, 
H. G. Identification of naturally processed viral nonapeptides allows their 
specific quantitation in infected cells and suggests an allele-specific T cell 
epitope forecast. J. Exp. Med. 174: 425, 1991. 
69. Townsend, A.R.M. , Rothbard, J., Gotch, F.M. Bahadur G., Wra:th, D. and 
McMichael, A.J. The epitopes of influenza nucleoprotein recognized by cytotoxic 
T lymphocytes can be defined with short synthetic peptides. Cell 44: 959-368, 
1986. 
69. Townsend, A.R.M., McMichael, A.J., Carter, N.P. Huddleston, J.A. and 
Brownlee, G.G. Cytotoxic T cell recognition of the influenza nucleoprotein and 
hemagglutinin expressed in transfected mouse L ceils. Cell 9: 13-25, 1984. 
70. Slomski, R. , Hagen, K., Kim, Y.S. and Cohen, E.P. Immunity to murine 
leukemia induced in susceptible mice by transfected mouse fibroblasts. Leukemi 
1: 213-219, 1987. 
[364] 
Recombinant DNA Research, Volume 18 
